Literature DB >> 25938991

The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study.

Pierluigi Costanzo, John G F Cleland, Pierpaolo Pellicori, Andrew L Clark, David Hepburn, Eric S Kilpatrick, Pasquale Perrone-Filardi, Jufen Zhang, Stephen L Atkin.   

Abstract

BACKGROUND: Whether obesity is associated with a better prognosis in patients with type 2 diabetes mellitus is controversial.
OBJECTIVE: To investigate the association between body weight and prognosis in a large cohort of patients with type 2 diabetes followed for a prolonged period.
DESIGN: Prospective cohort.
SETTING: National Health Service, England. PATIENTS: Patients with diabetes. MEASUREMENTS: The relationship between body mass index (BMI) and prognosis in patients with type 2 diabetes without known cardiovascular disease at baseline was investigated. Information on all-cause mortality and cardiovascular morbidity (such as the acute coronary syndrome, cerebrovascular accidents, and heart failure) was collected. Cox regression survival analysis, corrected for potential modifiers, including cardiovascular risk factors and comorbid conditions (such as cancer, chronic kidney disease, and lung disease), was done.
RESULTS: 10,568 patients were followed for a median of 10.6 years (interquartile range, 7.8 to 13.4). Median age was 63 years (interquartile range, 55 to 71), and 54% of patients were men. Overweight or obese patients (BMI >25 kg/m²) had a higher rate of cardiac events (such as the acute coronary syndrome and heart failure) than those of normal weight (BMI, 18.5 to 24.9 kg/m²). However, being overweight (BMI, 25 to 29.9 kg/m²) was associated with a lower mortality risk, whereas obese patients (BMI >30 kg/m²) had a mortality risk similar to that of normal-weight persons. Patients with low body weight had the worst prognosis. LIMITATION: Data about cause of death were not available.
CONCLUSION: In this cohort, patients with type 2 diabetes who were overweight or obese were more likely to be hospitalized for cardiovascular reasons. Being overweight was associated with a lower mortality risk, but being obese was not. PRIMARY FUNDING SOURCE: National Institute for Health Research and University of Hull.

Entities:  

Mesh:

Year:  2015        PMID: 25938991     DOI: 10.7326/M14-1551

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  57 in total

1.  Association of body mass index with all-cause mortality in patients with diabetes: a systemic review and meta-analysis.

Authors:  Hsiao-Wen Chang; Yi-Hwei Li; Chang-Hsun Hsieh; Pang-Yen Liu; Gen-Min Lin
Journal:  Cardiovasc Diagn Ther       Date:  2016-04

2.  Renal Function in Type 2 Diabetes Following Gastric Bypass.

Authors:  Adrian T Billeter; Stefan Kopf; Martin Zeier; Katharina Scheurlen; Lars Fischer; Thilo M Schulte; Hannes G Kenngott; Barbara Israel; Philipp Knefeli; Markus W Büchler; Peter P Nawroth; Beat P Müller-Stich
Journal:  Dtsch Arztebl Int       Date:  2016-12-09       Impact factor: 5.594

Review 3.  The obesity paradox and diabetes.

Authors:  Giovanni Gravina; Federica Ferrari; Grazia Nebbiai
Journal:  Eat Weight Disord       Date:  2020-09-20       Impact factor: 4.652

4.  Evolutionarily derived networks to inform disease pathways.

Authors:  Britney E Graham; Christian Darabos; Minjun Huang; Louis J Muglia; Jason H Moore; Scott M Williams
Journal:  Genet Epidemiol       Date:  2017-09-25       Impact factor: 2.135

5.  Gastric bypass simultaneously improves adipose tissue function and insulin-dependent type 2 diabetes mellitus.

Authors:  Adrian T Billeter; Spiros Vittas; Barbara Israel; Katharina M Scheurlen; Asa Hidmark; Thomas H Fleming; Stefan Kopf; Markus W Büchler; Beat P Müller-Stich
Journal:  Langenbecks Arch Surg       Date:  2017-07-09       Impact factor: 3.445

Review 6.  Mechanism of cardiovascular disease benefit of glucagon-like peptide 1 agonists.

Authors:  Josh Reed; Venkateswarlu Kanamarlapudi; Stephen Bain
Journal:  Cardiovasc Endocrinol Metab       Date:  2018-02-14

Review 7.  Adipokines and Migraine: A Systematic Review.

Authors:  B Lee Peterlin; Simona Sacco; Claudia Bernecker; Ann I Scher
Journal:  Headache       Date:  2016-03-25       Impact factor: 5.887

8.  Weight change after initiation of oral hypoglycemic monotherapy for diabetes predicts 5-year mortality: An observational study.

Authors:  Beverly M Kocarnik; Kathryn P Moore; Nicholas L Smith; Edward J Boyko
Journal:  Diabetes Res Clin Pract       Date:  2016-12-05       Impact factor: 5.602

9.  Chronic Kidney Disease and the Adiposity Paradox: Valid or Confounded?

Authors:  Susan L Ziolkowski; Jin Long; Joshua F Baker; Glenn M Chertow; Mary B Leonard
Journal:  J Ren Nutr       Date:  2019-01-29       Impact factor: 3.655

10.  A comparison of obesity indices in relation to mortality in type 2 diabetes: the Fremantle Diabetes Study.

Authors:  Joel Tate; Matthew Knuiman; Wendy A Davis; Timothy M E Davis; David G Bruce
Journal:  Diabetologia       Date:  2019-12-14       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.